Article
Transcriptomic-Assisted Immune and Neoantigen Profiling in Premalignancy.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2022
Chang Kyle, McAllister Florencia, Vilar Eduardo
Abstract excerpt
Immune-based cancer therapies such as checkpoint inhibitors (CPI) and vaccines have been increasingly studied across different cancer types. Response to such therapies depends on a number of factors such as mutational burden, neoantigen load, presence of tumor infiltrating lymphocytes, among others. Next-generation sequencing (NGS) technologies are particularly attractive to interrogate the immune response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
